| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 03/19/1997 | CN1145636A Vascular endothelial growth factor 2 |
| 03/18/1997 | US5612456 Factor XIII compositions |
| 03/18/1997 | US5612222 Human skin |
| 03/18/1997 | US5612103 Coatings for production of hyperpolarized noble gases |
| 03/18/1997 | US5612057 Acoustically reflective liposomes and methods to make and use same |
| 03/18/1997 | US5612019 Diagnosis and treatment of HIV viral infection using magnetic metal transferrin particles |
| 03/18/1997 | US5612018 Cyclosporin a for treatment of aids |
| 03/18/1997 | US5612016 Conjugates of antibodies and bifunctional ligands |
| 03/18/1997 | US5611344 Microencapsulated fluorinated gases for use as imaging agents |
| 03/18/1997 | US5611342 Method of computer tomography imaging the gastrointestinal tract and surrounding upper abdominal tissues and organs using an orally administered low density contrast medium |
| 03/18/1997 | CA2072559C Method for making liposomes of enhanced entrapping capacity toward foreign substances to be encapsulated |
| 03/13/1997 | WO1997009633A1 A method of determining oxygen concentration in a sample |
| 03/13/1997 | WO1997009051A1 Analogs for specific oligosaccharide-neuregulin interactions and uses thereof |
| 03/13/1997 | WO1997009043A1 Two-photon upconverting dyes and applications |
| 03/13/1997 | WO1997001360A3 Compounds with chelation affinity and selectivity for first transition series elements and their use in medical therapy and diagnosis |
| 03/13/1997 | WO1996040281A3 Gas emulsions stabilized with fluorinated ethers having low ostwald coefficients |
| 03/13/1997 | WO1996038184A3 Magnetic resonance imaging agents for the detection of physiological agents |
| 03/13/1997 | CA2231405A1 A method of determining oxygen concentration in a sample |
| 03/13/1997 | CA2231114A1 Two-photon upconverting dyes and applications |
| 03/13/1997 | CA2230385A1 Analogs for specific oliogosaccharide-neuregulin interactions and uses thereof |
| 03/12/1997 | EP0761233A2 Transkaryotic implantation |
| 03/12/1997 | EP0760809A1 Omega-hydrofluoroalkyl ethers, precursor carboxylic acids and derivatives thereof, and their preparation and application |
| 03/12/1997 | EP0760684A1 Gas filled microspheres as computed tomography contrast agents |
| 03/12/1997 | EP0760683A1 Bile acid conjugates, derivatives thereof with metal complexes and related uses |
| 03/12/1997 | EP0640067B1 Improved synthesis of ioversol |
| 03/12/1997 | EP0468997B1 Bacteriochlorophyll-a derivatives useful in photodynamic therapy |
| 03/12/1997 | CN1034242C Method and apparatus for screening cells or formed bodies |
| 03/11/1997 | US5610289 Backbone modified oligonucleotide analogues |
| 03/11/1997 | US5610013 Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors |
| 03/11/1997 | US5609851 Compounds which can be used in contrast products for radiography |
| 03/11/1997 | US5609850 Treated apatite particles for ultrasound imaging |
| 03/11/1997 | US5609847 Treatment methods using metal-binding targeted polypeptide constructs |
| 03/11/1997 | CA1338982C Detection of infectious and inflammatory lesions using anti-leukocyte antibody conjugates |
| 03/11/1997 | CA1338980C Bone cement for sustained release of substances |
| 03/05/1997 | EP0760365A2 Alkenyl-benzoylguanidines |
| 03/05/1997 | EP0759985A1 Transgenic arthritic mice |
| 03/05/1997 | EP0759786A1 Somatostatin binding peptide-metal chelate conjugates |
| 03/05/1997 | EP0759785A1 Liposome suspensions as blood pool imaging contrast agents |
| 03/05/1997 | EP0759769A1 Peptides and compounds that bind selectins including endothelium leukocyte adhesion molecule 1 (elam-1) |
| 03/05/1997 | EP0759758A1 Sialic acid/fucose based medicaments |
| 03/05/1997 | EP0759752A1 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
| 03/05/1997 | EP0759742A1 Physiologically acceptable emulsions containing perfluorocarbon ether hydrides and methods of use |
| 03/04/1997 | US5607924 DNA photocleavage using texaphyrins |
| 03/04/1997 | US5607661 Aggregates of x-ray microparticles for ultrasound imaging |
| 03/04/1997 | US5607660 X-ray contrast agents for intestines |
| 03/04/1997 | US5606973 Liquid core microdroplets for ultrasound imaging |
| 02/27/1997 | WO1997006833A1 Hyper comb-branched polymer conjugates |
| 02/27/1997 | WO1997006831A1 Methods of diagnostic image analysis using metal complexes of nitrogen-containing macrocyclic ligands |
| 02/27/1997 | WO1997006830A1 Methods of diagnostic image analysis using bioconjugates of metal complexes of nitrogen-containing macrocyclic ligands |
| 02/27/1997 | WO1997006829A1 The use of bile acid derivatives |
| 02/27/1997 | WO1997006824A2 Bioconjugates of manganese complexes and their application as catalysts |
| 02/27/1997 | WO1996040287A3 Preparation and use of contrast agents |
| 02/27/1997 | WO1996040280A3 Liquid core microdroplets for ultrasound imaging |
| 02/27/1997 | CA2229799A1 Bioconjugates of manganese complexes and their application as catalysts |
| 02/27/1997 | CA2229781A1 Methods of diagnostic image analysis using bioconjugates of metal complexes of nitrogen-containing macrocyclic ligands |
| 02/27/1997 | CA2229777A1 Methods of diagnostic image analysis using metal complexes of nitrogen-containing macrocyclic ligands |
| 02/27/1997 | CA2229530A1 The use of bile acid derivatives |
| 02/27/1997 | CA2226299A1 Hyper comb-branched polymer conjugates |
| 02/26/1997 | EP0759028A1 Method of detecting prions in a sample and transgenic animal used for same |
| 02/26/1997 | EP0758907A1 The use of porphyrin-complex or expanded porphyrin-complex compounds as localization diagnosticum for infarction or necrosis |
| 02/26/1997 | EP0758899A1 Permeabilizer peptides for increasing blood-ocular barrier permeability |
| 02/26/1997 | EP0758895A1 Dosage forms and method for ameliorating male erectile dysfunction |
| 02/26/1997 | EP0758887A1 Multifunctional ligand for use as a diagnostic or therapeutic pharmaceutical |
| 02/26/1997 | EP0730616A4 Process for preparing polyazamacrocycles |
| 02/26/1997 | EP0697884A4 Ligand precursors for incorporation into peptides |
| 02/25/1997 | US5606108 Process for preparing anionic polycarbonate and polyester oligomers having useful antiviral properties |
| 02/25/1997 | US5606045 Oligonucleotide linked to detectably labeled marker component which comprises porphyrin fluorophore moiety linked to two solubilizing polyoxyhydrocarbyl moieties |
| 02/25/1997 | US5605673 Surrounding a first and second gas with a membrane forming material such as a surfactant |
| 02/25/1997 | CA2183937A1 Alkenyl-benzoylguanidine derivatives |
| 02/20/1997 | WO1997006132A1 Triiodoalkylphenyl esters as novel x-ray contrast agents |
| 02/20/1997 | WO1997005906A2 Diagnostic and diagnosis method for central nervous abnormality and phenylketonuria |
| 02/20/1997 | WO1997005905A1 Novel 3-amido-triiodophenyl esters as x-ray contrast agents |
| 02/20/1997 | WO1997005904A2 Use of metal clusters as a contrast or radiotherapy agent |
| 02/20/1997 | WO1997000638A3 Apparatus and method for making gas-filled vesicles of optimal size |
| 02/20/1997 | WO1996033747A3 Water soluble fluorinated fatty acid sulfonate derivatives useful as magnetic resonance imaging agents |
| 02/20/1997 | CA2590360A1 Method for non-invasive blood analyte measurement with improved optical interface |
| 02/19/1997 | EP0758331A1 Polyethylene glycol derivatised dihydro or tetrahydro porphyrins, their preparation and their use as tumour localising, photosensitising compounds |
| 02/19/1997 | EP0758251A1 Composition for ultrasonically quantitating myocardial perfusion |
| 02/19/1997 | EP0758250A1 Texaphyrin solid-supports and devices |
| 02/19/1997 | CN1143076A 4-fluoroalkyl substituted phenacyl guanidine, its preparing method, application as medicine or diagnosis agent and medicine containing such compound |
| 02/18/1997 | US5604108 Test for determining the dose response of a conjugated vaccine |
| 02/18/1997 | US5604097 Methods for sorting polynucleotides using oligonucleotide tags |
| 02/18/1997 | US5603917 Recording in vivo measurements of intensity of magnetic resonance signal from xenobiotic compound, determining concentration by comparison of signal intensity with that of standard |
| 02/18/1997 | US5603916 Useful in x-ray diagnostic imaging as a contrast agent |
| 02/13/1997 | WO1997005484A1 A method of and test kit for mutagenesis testing |
| 02/13/1997 | WO1997004814A1 Detecting prions in a sample and prion preparation and transgenic animal used for same |
| 02/13/1997 | WO1997004813A1 Cellulose diacetate compositions for use in embolizing blood vessels |
| 02/13/1997 | WO1997004812A2 Pulmonary ventilation imagery agents |
| 02/13/1997 | WO1997004811A2 Use of liposomal preparations in indirect mri lymphography |
| 02/13/1997 | WO1997004796A1 Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations |
| 02/13/1997 | WO1997004756A2 Methacrylate backbone surfactants in nanoparticulate formulations |
| 02/13/1997 | WO1997004657A1 Novel embolizing compositions |
| 02/13/1997 | WO1997004656A1 Novel compositions for use in embolizing blood vessels |
| 02/13/1997 | WO1996040274A3 Chelating polymers as contrast agents for medical imaging |
| 02/13/1997 | CA2227328A1 Detecting prions in a sample and prion preparation and transgenic animal used for same |
| 02/13/1997 | CA2224492A1 A method of and test kit for mutagenesis testing |
| 02/13/1997 | CA2215311A1 Cellulose diacetate compositions for use in embolizing blood vessels |
| 02/13/1997 | CA2215272A1 Novel compositions for use in embolizing blood vessels |
| 02/12/1997 | EP0757888A1 Helicobacter pylori-colonized mongolian gerbil, process for preparation thereof, medium for separating helicobacter pylori, and method of screening anti-helicobacter pylori-active substance by using the same |
| 02/12/1997 | EP0757690A1 Electron-deficient porphyrins and processes and intermediates for preparing same |